Earnings
HEALWELL Achieves Record Q3 Revenue Growth Now as a Pure-Play Global SaaS, Services & AI Company for Health Systems and Life Sciences
AIDX · Price
Executive Summary
- HEALWELL AI Inc. reported Q3‑2025 revenue of $30.4 M, a 354% YoY increase driven primarily by the Orion Health acquisition.
- Adjusted EBITDA turned positive at $0.7 M (vs. a $2.8 M loss in Q3‑2024), marking the second consecutive quarter of profitability on an adjusted basis.
- The company completed strategic divestitures and acquired full ownership of Pentavere Research Group, raising cash to $15.6 M plus $9.4 M from recent sales, positioning HEALWELL as a pure‑play AI SaaS healthcare firm.
Key Details
- Revenue: $30.4 M in Q3‑2025 vs. $6.7 M in Q3‑2024 (+354%).
- Gross Profit: $16.5 M (+330% YoY); Gross margin 54% (down from 57%).
- Adjusted EBITDA: $0.7 M (positive) vs. a loss of $2.8 M in the prior year; +125% YoY.
- IFRS Net Loss (continuing ops): $16.0 M vs. $8.7 M loss YoY.
- Cash Position: $15.6 M as of Sep‑30‑2025 (up from $9.4 M Dec‑31‑2024). Recent divestments added $9.4 M cash.
Business Highlights
- Full ownership of Pentavere Research Group Inc.: Exercised call option on July 16 2025 to acquire remaining 49% stake, integrating DARWEN™ AI platform.
- Intrahealth EMR deployment: Selected by Public Health Sudbury & Districts (Sept 18 2025) to implement the Profile EMR system.
- Global launch of AmadeusAI: Integrated HEALWELL’s DARWEN™ AI with Orion Health’s Amadeus platform (Sept 25 2025).
Post‑Quarter Activities
- Regulatory‑grade RWD generation: Presented AI‑generated real‑world data at UEG Week in Berlin (Oct 6 2025) in collaboration with a major pharma firm.
- UK Investor & Business Development Tour: Series of meetings and an invitation‑only event in London (Oct 14 2025).
- Middle‑East Collaboration: Partnered with Lean Business Services and Orion Health to co‑develop AI solutions across the region (Oct 28 2025).
Strategic Divestitures (completed Nov 3 2025)
- Sold Polyclinic Family Medicine & Specialty Clinics to WELL Health Clinic Network.
- Formed 50/50 joint venture “WELL Research LP” with WELL Health Technologies Corp.
- Sold majority interest in Mutuo Health Solutions to WELLSTAR Technologies Corp.
- Cash proceeds: Approximately $9.7 M, strengthening balance sheet and supporting transition to a pure‑play AI SaaS model.
Conference Call
- Date & Time: Friday, 2025‑11‑07 at 8:30 am ET / 5:30 am PT.
- Participants: James Lee (CEO), Dr. Alexander Dobranowski (President), Anthony Lam (CFO).
- Webcast link: https://www.gowebcasting.com/14389
Selected Financial Tables (excerpt)
| Metric | Q3‑2025 ($ ‘000) | Q3‑2024 ($ ‘000) | YoY % |
|---|---|---|---|
| Revenue | 30,354 | 6,688 | +354% |
| Gross Profit | 16,510 | 3,838 | +330% |
| Adjusted EBITDA | 713 | (2,834) | +125% |
| Cash (end of quarter) | 15,600 | 9,400 | — |
| Subscription/Support Revenue | 21,014 | 3,310 | +535% |
Segment Revenue
- Healthcare Software: $28.4 M (+408% YoY).
- AI & Data Sciences: $2.0 M (+79% YoY).
Notable Quotes
“We are pleased to report HEALWELL's second consecutive quarter of positive Adjusted EBITDA…These strategic divestments allow us to sharpen our focus on becoming a pure‑play AI and SaaS healthcare company.” – James Lee, CEO
“Revenue from continuing operations grew 354% year‑over‑year, reflecting the contribution of Orion Health and other strategic initiatives.” – Anthony Lam, CFO
More from HEALWELL AI INC. J CL A SV
Jun 17, 2026 · 12:10